Drug Database
LE

leuprolide acetate (Leupronax)

✓ Approved

Nanox · GNRH1 · 小分子

什么是 leuprolide acetate?

leuprolide acetate 是一种小分子,由Nanox研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection。

药物档案

商品名Leupronax
公司Nanox
药物类别小分子, 多肽类
分子靶点GNRH1
给药途径Injectable (Others), Intramuscular (IM) Injection
状态Approved

作用机制

分子靶点

leuprolide acetate 作用于 1 个分子靶点:

GNRH1gonadotropin releasing hormone 1 (GNRH, LHRH)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

leuprolide acetate 针对 4 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Breast cancer✓ Approved
Reproductive system and breast disordersEndometriosis✓ Approved
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Prostate cancer✓ Approved
Reproductive system and breast disordersUterine fibrosis✓ Approved

相关研究文献

PubMedOrganic & biomolecular chemistry2026-11-17

A simple benzene triimide receptor with nitrobenzyl arms for the colorimetric sensing of anions.

Shymon Daryna D, Martinez Alexandre A, Cotelle Yoann Y

Benzene triimides (BTIs) have emerged as efficient platforms for the sensing of anions within molecular cages thanks to their highly electron deficient π-surfaces. Indeed, the combination of a confined environment with anion-π interactions greatly enhances anion binding affinity. However, single BTI surfaces fail to provide high binding constants for anions, thus excluding their use as efficient anion receptors. Hereby, we demonstrate that the incorporation of para-nitrobenzyl arms on BTIs leads to the efficient and selective recognition of acetate and iodide ions which can be followed by UV-visible spectroscopy.

PMID 43042623
阅读全文 →
PubMedACS nano2026-11-17

Highly Interconnected Cellulose Acetate Ultrafiltration Membranes via Interfacial Hydration-Induced Phase Separation for Ultrafast Water Purification.

Cao Dan D, Xiang Jun J, Zhao Peng P, Chen Xi X et al.

Ultrafiltration is essential for ensuring water security, yet commercial ultrafiltration membranes remain constrained by the permeability-selectivity trade-off. While extensive research has focused on designing the selective skin layer, such improvements in permeance have neared a bottleneck due to the often-overlooked hydraulic resistance arising from the underlying sponge-like layer. Here, we propose a generalizable interfacial hydration-induced phase separation strategy to reconstruct the internal transport channels within the sponge-like layer of biodegradable cellulose acetate (CA) ultrafiltration membranes, enhancing permeance without sacrificing selectivity. Specifically, highly polar nanoclusters (TCZ), formed in situ via multidentate coordination between tannic acid-modified cellulose nanocrystals (TC) and Zr4+ ions, preferentially anchor within the sponge-like layer through strong interfacial interactions with the CA matrix. Acting as localized hydration seeds, these nanoclusters attract and enrich water molecules to establish water-rich microenvironments through strong hydrogen-bonding interactions, promoting local liquid-liquid demixing and driving the formation of highly interconnected, low-tortuosity water-transport pathways throughout the sponge-like layer. The resulting CTCZ membranes exhibit high water permeance (752.29 L m-2 h-1 bar-1), representing a 10-fold increase over the CA membrane, with high rejection (>96%) for typical water contaminants. Notably, this strategy can also be extended to mainstream polyvinylidene fluoride and poly(ether sulfone) matrices, yielding 13-fold and 21-fold permeance enhancements, respectively. Large-area NW-CTCZ membranes fabricated via a roll-to-roll process demonstrate reliable long-term stability in surface water purification. Furthermore, life-cycle and economic analyses confirm that the CTCZ membranes, as eco-friendly and cost-effective candidates, offer a scalable and sustainable approach for water treatment.

PMID 43043211
阅读全文 →
PubMedNatural product research2026-11-17

Antioxidant and antiproliferative effects of flavonoid fractions from Citri Exocarpium Rubrum on A549 lung cancer cells and their underlying mechanisms by network pharmacology.

Wang Jinling J, Zeng Shiyuan S, Lu Haixiao H, Chen Yukai Y et al.

Lung cancer remains a leading cause of cancer mortality, with chemotherapy resistance limiting treatment efficacy. Citri Exocarpium Rubrum (CER), a flavonoid-rich traditional Chinese medicine, exhibits anticancer potential. This study investigated its antioxidant and antiproliferative effects against A549 lung cancer cells and the underlying mechanisms. Flavonoids were extracted from CER and partitioned into ethyl acetate and n-butanol fractions. Antioxidant capacity and antiproliferative effects were assessed by 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays, respectively. Mitochondrial membrane potential (MMP) and apoptosis were measured. Network pharmacology was conducted using TCMSP, SwissTargetPrediction and GeneCards, followed by GO and KEGG enrichment analyses. Both fractions showed concentration-dependent DPPH radical scavenging (73.66% and 84.36% at 32 μg/mL) and inhibited A549 proliferation. The n-butanol fraction induced dose-dependent apoptosis with reduced MMP. Network pharmacology identified 6 active components, 255 targets, 5 hub targets (SRC, ESR1, BCL2, HSP90AA1, PPARG) and 20 enriched pathways related to cancer and calcium signalling. CER flavonoid fractions demonstrate antioxidant and antiproliferative activities against A549 cells via multi-component, multi-target mechanisms, supporting its potential clinical application in lung cancer therapy.

PMID 43042661
阅读全文 →
PubMedBiomedical chromatography : BMC2026-11-17

Determination of Apalutamide in Human Plasma by Sensitive LC-MS/MS Method and the Application to a Bioequivalence Study.

Lu Ting T, Xiong Dan D, Yuan Zhao Z, Xu Man M et al.

A highly robust and high-throughput liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay was developed and validated for the quantification of apalutamide in human plasma. Chromatographic separation was achieved on a ZORBAX Eclipse XDB-C18 column via gradient elution, using a mobile phase comprising acetonitrile and 0.1% formic acid with 5-mM ammonium acetate. The method featured a broad linear dynamic range of 1.00-2500 ng/mL. Furthermore, the assay exhibited exceptional selectivity and matrix resistance across normal, hyperlipidemic, and hemolyzed blank matrices. Validation results demonstrated high reliability: Intra-batch and inter-batch precision (CV) were ≤ 6.6%, with accuracies (RE) strictly within ±3.4%. Mean extraction recoveries for apalutamide and the internal standard exceeded 102%. This method was applied to evaluate the pharmacokinetics of a single 60-mg apalutamide dose in 60 healthy Chinese male volunteers under both fasting and fed conditions. The 90% confidence intervals for the geometric mean ratios of all primary pharmacokinetic parameters fell within the regulatory 80%-125% equivalence limits. Consequently, the test and reference formulations were confirmed to be bioequivalent. The 60-mg oral dosage was well tolerated by all subjects, with no serious adverse events or adverse events exceeding Grade 1 observed during the trial.

PMID 43041122
阅读全文 →
PubMedBiomedical chromatography : BMC2026-11-17

Simultaneous Quantification of Acetaminophen and Oxycodone in Human Plasma by UPLC-MS/MS and Its Application to Pharmacokinetic Study of Single-Dose and Multiple-Dose Administrations.

Tang Wei-Ying WY, Yang Shan-Shan SS, Wei Yu-Tao YT, Yang Min M et al.

In this study, a novel ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method with high sensitivity, high efficiency, and easy operation was established and validated for the simultaneous quantification of acetaminophen (APAP) and oxycodone (OC) in human plasma. Sample preparation involved protein precipitation with acetonitrile, followed by nitrogen evaporation, and the separation was achieved by a Waters BEH column (2.1 mm × 50 mm, 1.7 μm) with a gradient elution using acetonitrile, ammonium acetate buffer, and formic acid as the mobile phase. The detection of APAP (m/z 152.1 → 110.2) and OC (m/z 316.0 → 241.2) was performed using multiple reaction monitoring (MRM) mode with positive electrospray ionization (ESI). APAP-d3 (m/z 155.1 → 111.1) and OC-d3 (m/z 319.2 → 244.2) were used as internal standards. The calibration curves showed good linear relationships over the concentration ranges of 0.0500-12.0 μg/mL for APAP and 0.100-24.0 ng/mL for OC, respectively, using a weighted (1/x2) linear regression model. The intra- and inter-day accuracy bias was in the range of -1.1% to 6.2% (RSD ≤ 6.3%). Recovery, specificity, matrix effect, and stability were also assessed. This high-throughput method was successfully applied to compare the pharmacokinetics of extended-release and immediate-release OC/APAP tablets in chronic pain patients and to evaluate the food effect on the extended-release formulation.

PMID 43041136
阅读全文 →
PubMedNational science review2026-11-17

Key engineering innovations in industrial-scale cyclohexanone production via cyclohexene esterification-reduction.

Zong Baoning B, Ma Dongqiang D, Shi Yanqiang Y, Zhao Junqi J et al.

Conventional industrial technologies for the production of cyclohexanone, a key precursor to ε-caprolactam, mainly including cyclohexane oxidation (CHA-Ox) and cyclohexene hydration (CHE-Hydr), are constrained by an inherent trade-off between conversion and selectivity. This leads to low carbon atom utilization or high energy intensity, together with substantial environmental burdens. The cyclohexene esterification-reduction (CHE-ER) route, first proposed by the Research Institute of Petroleum Processing, delivers exceptional conversion and selectivity and therefore offers a promising platform for next-generation cyclohexanone production. However, the central challenge has been to translate the intrinsic advantages of this chemistry into a process that is simultaneously economically competitive and environmentally sustainable. Here we report a set of critical chemical engineering innovations that streamline process design and substantially reduce energy consumption. By leveraging the inertness of cyclohexane during cyclohexene esterification, we designed a new extraction system that selectively separates benzene from its partial hydrogenation products. We further implemented a hybrid reactor configuration integrating a fixed-bed reactor with a catalytic reactive distillation reactor for cyclohexene esterification with acetic acid. In addition, we identified and strategically harnessed the beneficial roles of cyclohexane in facilitating reaction heat dissipation and excess acetic acid separation. These innovations have been successfully deployed in a 400 kt yr-1-capacity industrial plant for cyclohexanone production via the CHE-ER route, affording nearly complete cyclohexene conversion and cyclohexyl acetate selectivity above 99.0%. This work establishes a new-generation industrial technology for cyclohexanone production that maximizes economic benefit, while minimizing energy demand and environmental impacts associated with conventional processes.

PMID 43042036
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多leuprolide acetate